Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.34 +0.19 (+4.58%)
At close: Nov 11, 2026 · 4:00 PM EST

Aclaris Therapeutics (ACRS) Change in Intangibles (2025)

Updated

Aclaris Therapeutics' Change in Intangibles was $833,000 in Q1 2025.

Analysis

Aclaris Therapeutics (ACRS) Change in Intangibles (2025) Analysis & Trends

For FY2024, Change in Intangibles at Aclaris Therapeutics came in at $35.81 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.06 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 995.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -7.20 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Aclaris Therapeutics 625.92 Mn 223.91 Mn 1.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 833,000.00
API Access

Aclaris Therapeutics Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=ACRS&period=max&api_key=YOUR_API_KEY